CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net income	$ 72,920	$ 72,573
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	21,370	20,416
Amortization	12,569	11,935
Amortization of deferred financing costs	1,142	1,296
Deferred income taxes	(11,505)	(11,793)
Share based compensation expense	5,786	5,434
Stock option income tax benefit	(69)	(603)
Equity in earnings from unconsolidated affiliates	290	1,779
Other non-cash expense	(3,405)	20,016
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(22,920)	(37,637)
Inventories, net	(15,180)	(22,080)
Prepaid expenses and other current assets	(5,751)	10,638
Other noncurrent assets, net	1,465	2,232
Accounts payable	8,047	(10,928)
Accrued liabilities	(21,901)	(8,558)
Income taxes payable	23,423	(21,196)
Other noncurrent liabilities	(1,716)	2,562
Net cash provided by operating activities	64,565	36,086
Cash flows from investing activities:
Capital expenditures	(25,322)	(24,032)
Cash paid for acquisitions of businesses, net of cash acquired	0	(3,939)
Proceeds from Hedge, Investing Activities	864	0
Payments for Derivative Instrument, Investing Activities	2,103	45,765
Expenditures for identifiable intangible assets	(1,305)	(205)
Proceeds from sale of property, plant and equipment, net	168	1,218
Net cash used in investing activities	(28,842)	(72,723)
Cash flows from financing activities:
Net change in short-term borrowings	64,886	16,133
Cash paid for treasury stock	(40,395)	0
Cash dividends paid	(8,979)	(7,909)
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	(33)	(8,960)
Repayments on long-term borrowings	(75,174)	0
Proceeds from exercise of stock options	4,149	13,578
Excess tax benefits from share based compensation	69	603
Proceeds from Derivative Instrument, Financing Activities	0	464
Payments for Derivative Instrument, Financing Activities	0	306
Net cash used in financing activities	(55,477)	13,603
Effect of exchange rate changes on cash and cash equivalents	623	(895)
Net (decrease) increase in cash and cash equivalents	(19,131)	(23,929)
Cash and cash equivalents at beginning of period	74,954
Cash and cash equivalents at end of period	55,823
Purchase of short-term investments	$ 1,144	$ 0